Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2012
11/01/2012WO2012146934A1 Binding molecules with biased recognition
11/01/2012WO2012146628A1 Novel immunoconjugates
11/01/2012WO2012146394A1 Dosage regimen for administering a cd19xcd3 bispecific antibody to patients at risk for potential adverse effects
11/01/2012WO2012121775A3 Il-1 -alpha and -beta bispecific dual variable domain immunoglobulins and their use
11/01/2012WO2012119004A3 Parathyroid hormone analogs, compositions and uses thereof
11/01/2012WO2012109373A3 Treatment of osteoarthritis and pain
11/01/2012WO2012103324A3 Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto
11/01/2012WO2012099949A3 Antibody purification via affinity chromatography
11/01/2012WO2012075340A3 Anti-ngf compositions and use thereof
11/01/2012WO2012061374A3 Dual variable domain immunoglobulins and uses thereof
11/01/2012US20120278909 Compositions and methods for determining genetic polymorphisms in the tmem216 gene
11/01/2012US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters
11/01/2012US20120276570 Peptide Antibody Depletion and its Application to Mass Spectrometry Sample Preparation
11/01/2012US20120276562 5.9 kDa PEPTIDE IMMUNOASSAY METHOD
11/01/2012US20120276561 Marker protein for type-2 diabetes
11/01/2012US20120276548 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
11/01/2012US20120276536 Hair Shape Susceptibility Gene
11/01/2012US20120276529 Mutated sumo isoforms and uses thereof
11/01/2012US20120276528 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
11/01/2012US20120276141 Env polypeptide complexes and methods of use
11/01/2012US20120276135 Methods for improving the design, bioavailability, and efficacy of random sequence polymer compositions via serum protein-based detection of random sequence polymer compositions
11/01/2012US20120276131 Anti-trypanosomiasis vaccines and diagnostics
11/01/2012US20120276129 Neisserial antigenic peptides
11/01/2012US20120276128 HIV Envelope-CD4 Complexes and Hybrids
11/01/2012US20120276125 Novel immunoconjugates
11/01/2012US20120276123 Anticoagulant antidotes
11/01/2012US20120276122 Methods for diagnosis and treatment of cellular proliferative disorders
11/01/2012US20120276120 T-Cell Stimulating Protein B and Methods of Use
11/01/2012US20120276119 CD37-Binding Molecules and Immunoconjugates Thereof
11/01/2012US20120276117 Binding Partners for the Thyrotropin Receptor and Uses Thereof
11/01/2012US20120276116 Prevention and Treatment of Amyloidogenic Disease
11/01/2012US20120276115 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
11/01/2012US20120276113 Methods of treating and preventing colitis involving il-13 and nk-t cells
11/01/2012US20120276107 Methods and Compositions for Mycoplasma Pneumoniae Exotoxins
11/01/2012US20120276104 Multispecific modular antibody
11/01/2012US20120276103 Vhh for application in tissue repair, organ regeneration, organ replacement and tissue engineering
11/01/2012US20120276101 Viral chemokine-antigen fusion proteins
11/01/2012US20120276092 Antibody Glycosylation Variants
11/01/2012US20120276091 Human Recombinant Monoclonal Antibody That Specifically Binds to VCAM-1 and Inhibits Adhesion and Transmigration Between Leukocytes and Endothelial Cells
11/01/2012US20120276090 Gene recombinant antibody and antibody fragment thereof
11/01/2012US20120276086 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
11/01/2012US20120276082 Treatment of cancer
11/01/2012US20120276046 Anti ganglioside gd3 antibodies and uses thereof
11/01/2012US20120276010 Microorganisms for therapy
11/01/2012US20120276009 Pharmaceutical composition
11/01/2012US20120276002 Contrast agent for optical imaging, use thereof and apparatus using the same
11/01/2012US20120275997 Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2834626A1 Therapeutic nuclease compositions and methods
11/01/2012CA2834552A1 Ip-10 antibody dosage escalation regimens
11/01/2012CA2834535A1 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
11/01/2012CA2834404A1 Anti-cd40 antibodies and methods of use
11/01/2012CA2834376A1 Neutralizing antibodies to nipah and hendra virus
11/01/2012CA2834243A1 Anti-human receptor-type protein tyrosine phosphatase .sigma. antibody
11/01/2012CA2834136A1 Anti-b7-h3 antibody
11/01/2012CA2833917A1 Identification of polynucleotides associated with a sample
11/01/2012CA2832360A1 Dosage regimen for administering a cd19xcd3 bispecific antibody to patients at risk for potential adverse effects
11/01/2012CA2832341A1 Dna removal in target molecule purification
11/01/2012CA2831008A1 Novel immunoconjugates
10/2012
10/31/2012EP2518496A2 BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
10/31/2012EP2518085A1 IL-17 receptor A antigen binding proteins
10/31/2012EP2518084A1 Method for measuring human insulin and measurement reagent
10/31/2012EP2518083A2 Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or FLTL antagonist for treating cancer
10/31/2012EP2517730A2 Vitamin receptor binding drug delivery conjugates
10/31/2012EP2517729A2 Vitamin receptor binding drug delivery conjugates
10/31/2012EP2517557A2 Animal models and therapeutic molecules
10/31/2012EP2517556A2 Animal models and therapeutic molecules
10/31/2012EP2516646A2 Method of treatment and screening method
10/31/2012EP2516624A1 Cell line 3m
10/31/2012EP2516470A1 Antibodies to non-functional oligomeric p2x7 receptors
10/31/2012EP2516469A1 Anti-her3 antibodies and uses thereof
10/31/2012EP2516468A1 Anti-flt3 antibodies and methods of using the same
10/31/2012EP2516467A2 Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof
10/31/2012EP2516466A2 Human antibodies to human angiopoietin-like protein 4
10/31/2012EP2516465A1 Anti-bv8 antibodies and uses thereof
10/31/2012EP2516464A1 Recombinant factor h and variants and conjugates thereof
10/31/2012EP2516463A1 Binding members for human cytomegalovirus
10/31/2012EP2516462A1 Immuno-conjugates and methods for producing them 2
10/31/2012EP2516461A1 Method for decreasing immunogenicity
10/31/2012EP2516460A1 Sequence dependent aggregation
10/31/2012EP2516458A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy
10/31/2012EP2515941A1 Antibody formulation
10/31/2012EP2515935A1 A method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection
10/31/2012CN1835977B CD20-binding polypeptide compositions
10/31/2012CN1612750B TACI-immunoglobulin fusion proteins
10/31/2012CN102762728A Methods for producing antibody-producing cells that produce desired polypeptides
10/31/2012CN102762595A Antibodies to non-functional oligomeric p2x7 receptors
10/31/2012CN102762594A Trispecific therapeutics against acute myeloid leukaemia
10/31/2012CN102762593A Fully human antibodies to btla
10/31/2012CN102762592A Non-human mammal model of human hematopoietic cancer
10/31/2012CN102762588A Anti-trypanosome therapeutic and diagnostic applications
10/31/2012CN102762585A Single unit antibody purification
10/31/2012CN102762228A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
10/31/2012CN102762221A Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
10/31/2012CN102757505A Physiologically active polypeptide conjugate having prolonged in vivo half-life
10/31/2012CN102757499A Antibody for resisting osteopontin chimerism, preparation method and application thereof in preparation of drugs for treating osteoporosis
10/31/2012CN102757498A Bifunctional antibody for resisting four serotype dengue viruses and application thereof in preparation of drugs for resisting dengue virus infection
10/31/2012CN102757497A Anti-PEDF monoclonal antibody, and preparation method and application thereof
10/31/2012CN102757496A Method for purifying and preparing anti-VEGF antibody fragment
10/31/2012CN102757495A Holistic anti-VEGF antibody, preparation method and application thereof
1 ... 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 ... 1494